Cargando…
Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma
The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and insulin-like growth factor 1 (IGF1) has been proposed for treatment, but they do not persist in the middle ear becaus...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198354/ https://www.ncbi.nlm.nih.gov/pubmed/34072013 http://dx.doi.org/10.3390/ijms22115720 |
_version_ | 1783707118312882176 |
---|---|
author | Cho, Jung-Ah Kim, Bong Jik Hwang, Yu-Jung Woo, Shin-Wook Noh, Tae-Soo Suh, Myung-Whan |
author_facet | Cho, Jung-Ah Kim, Bong Jik Hwang, Yu-Jung Woo, Shin-Wook Noh, Tae-Soo Suh, Myung-Whan |
author_sort | Cho, Jung-Ah |
collection | PubMed |
description | The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and insulin-like growth factor 1 (IGF1) has been proposed for treatment, but they do not persist in the middle ear because they are typically delivered in fluid form. We developed a dual-vehicle drug delivery system consisting of cross-linked hyaluronic acid and polylactide-co-glycolide microcapsules. The effect and biocompatibility of the dual vehicle in delivering D and IGF1 were evaluated using an animal model of acute acoustic trauma. The dual vehicle persisted 10.9 times longer (8.7 days) in the middle ear compared with the control (standard-of-care vehicle, 0.8 days). The dual vehicle was able to sustain drug release over up to 1 to 2 months when indocyanine green was loaded as the drug. One-third of the animals experienced an inflammatory adverse reaction. However, it was transient with no sequelae, which was validated by micro CT findings, endoscopic examination, and histological assessment. Hearing restoration after acoustic trauma was satisfactory in both groups, which was further supported by comparable numbers of viable hair cells. Overall, the use of a dual vehicle for intratympanic D and IGF1 delivery may maximize the effect of drug delivery to the target organ because the residence time of the vehicle is prolonged. |
format | Online Article Text |
id | pubmed-8198354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81983542021-06-14 Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma Cho, Jung-Ah Kim, Bong Jik Hwang, Yu-Jung Woo, Shin-Wook Noh, Tae-Soo Suh, Myung-Whan Int J Mol Sci Article The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and insulin-like growth factor 1 (IGF1) has been proposed for treatment, but they do not persist in the middle ear because they are typically delivered in fluid form. We developed a dual-vehicle drug delivery system consisting of cross-linked hyaluronic acid and polylactide-co-glycolide microcapsules. The effect and biocompatibility of the dual vehicle in delivering D and IGF1 were evaluated using an animal model of acute acoustic trauma. The dual vehicle persisted 10.9 times longer (8.7 days) in the middle ear compared with the control (standard-of-care vehicle, 0.8 days). The dual vehicle was able to sustain drug release over up to 1 to 2 months when indocyanine green was loaded as the drug. One-third of the animals experienced an inflammatory adverse reaction. However, it was transient with no sequelae, which was validated by micro CT findings, endoscopic examination, and histological assessment. Hearing restoration after acoustic trauma was satisfactory in both groups, which was further supported by comparable numbers of viable hair cells. Overall, the use of a dual vehicle for intratympanic D and IGF1 delivery may maximize the effect of drug delivery to the target organ because the residence time of the vehicle is prolonged. MDPI 2021-05-27 /pmc/articles/PMC8198354/ /pubmed/34072013 http://dx.doi.org/10.3390/ijms22115720 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cho, Jung-Ah Kim, Bong Jik Hwang, Yu-Jung Woo, Shin-Wook Noh, Tae-Soo Suh, Myung-Whan Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title | Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title_full | Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title_fullStr | Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title_full_unstemmed | Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title_short | Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma |
title_sort | effect and biocompatibility of a cross-linked hyaluronic acid and polylactide-co-glycolide microcapsule vehicle in intratympanic drug delivery for treating acute acoustic trauma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198354/ https://www.ncbi.nlm.nih.gov/pubmed/34072013 http://dx.doi.org/10.3390/ijms22115720 |
work_keys_str_mv | AT chojungah effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma AT kimbongjik effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma AT hwangyujung effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma AT wooshinwook effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma AT nohtaesoo effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma AT suhmyungwhan effectandbiocompatibilityofacrosslinkedhyaluronicacidandpolylactidecoglycolidemicrocapsulevehicleinintratympanicdrugdeliveryfortreatingacuteacoustictrauma |